Viewing Study NCT02411435


Ignite Creation Date: 2025-12-24 @ 10:19 PM
Ignite Modification Date: 2026-01-17 @ 11:50 PM
Study NCT ID: NCT02411435
Status: COMPLETED
Last Update Posted: 2016-01-06
First Post: 2015-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
Sponsor: ViiV Healthcare
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 117010
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View